Argenx (ARGX) Stock Highlights

537.47 | +1.59%

2024-09-19 15:38:13

argenx SE is an immunology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The group has partnered with academic researchers through its Immunology Innovation Program (IIP) and aims to translate immunology breakthroughs into a portfolio of novel antibody-based medicines. argenx developed and is commercializing the neonatal Fc receptor (FcRn) blocker in the U.S., Japan, and the EU. Its product pipeline includes product candidates such as ARGX-117, ARGX-118, ARGX-115, ARGX-116, and others.

Statistics

Range Today

529.69 538.31

Volume Today 51.68K

Range 1 Year

327.73 554.74

Volume 1 Year 85.87M

Range 3 Year

249.5 554.74

Volume 3 Year 211.63M

Range 10 Year

17.33 554.74

Volume 10 Year 391.29M

Highlights

Market Capitalization 32.54B (large)

Floating Shares 59.4M

Current Price 537.47

Price To Earnings -154.66

Price To Revenue 17.54

Price To Book 7.55

Earnings Per Share -3.48

Payout Ratio 0%

Performance

Latest +1.59%

1 Month +3.38%

3 Months +40.37%

6 Months +48.05%

1 Year +3.11%

3 Years +66.04%

5 Years +321.25%

10 Years +2902.63%

Benchmarks

Market Capitalization

5 / 368

Gross Profits

268 / 278

Total Revenue

18 / 300

Total Rank

292 / 368

Free Cashflow

0 / 352

Performance 5 years

21 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.